A patient who tolerates a graduated dose increase and reaches 2.4 mg consistently will achieve better long-term outcomes than one who starts high, experiences severe side effects, and must stop treatment
One hour visit reviewing your medical conditions, current state of health, and weight loss goals
Obesity is a primary risk factor, as excess weight can increase pressure within the colon
Youll also receive ongoing support to ensure you are meeting your weight loss goals
Vi lyssnar p vra klienter och lgger ned den tid som behvs
In Phase II trials, MariTide demonstrated up to approximately 20% average weight loss at 52 weeks in people living with obesity or overweight, without evidence of a plateau, suggesting even greater results with longer treatment